{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:01:00Z","timestamp":1792342860107,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.healun.2010.01.005","type":"journal-article","created":{"date-parts":[[2010,3,21]],"date-time":"2010-03-21T04:22:02Z","timestamp":1269145322000},"page":"641-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation"],"prefix":"10.1016","volume":"29","author":[{"given":"Einar","family":"Gude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gullestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Hoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallvard","family":"Holdaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnt E.","family":"Fiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odd R.","family":"Geiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne K.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2010.01.005_bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.healun.2008.06.017","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report\u20142008","volume":"27","author":"Taylor","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.107.711911","article-title":"Cardiac allograft vasculopathy: recent developments","volume":"117","author":"Schmauss","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2010.01.005_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1432-2277.2004.00001.x","article-title":"C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients","volume":"1","author":"Caforio","year":"2005","journal-title":"Transplant Int"},{"key":"10.1016\/j.healun.2010.01.005_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.tp.0000268810.61393.2c","article-title":"Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy","volume":"84","author":"Arora","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2010.01.005_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-6143.2008.02490.x","article-title":"The clinical impact of an early decline in kidney function in patients following heart transplantation","volume":"9","author":"Cantarovich","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib6","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.transproceed.2007.09.008","article-title":"Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy","volume":"10","author":"Chapman","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2010.01.005_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/HCO.0b013e328012545e","article-title":"Proliferation signal inhibitors in cardiac transplantation","volume":"2","author":"Gustafsson","year":"2007","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.healun.2010.01.005_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.healun.2007.01.010","article-title":"Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German\u2013Austrian Certican Consensus Conference","volume":"4","author":"Rothenburger","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2010.01.005_bib10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.healun.2007.02.008","article-title":"Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients","volume":"7","author":"Lehmkuhl","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib11","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/j.1600-6143.2005.01019.x","article-title":"Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus","volume":"5","author":"Meier-Kriesche","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib12","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1600-6143.2004.00624.x","article-title":"Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/TP.0b013e31819452ce","article-title":"Progression of renal dysfunction in cardiac transplantation after the introduction of everolimus in the immunosuppressive regime","volume":"87","author":"Moro L\u00f3pez","year":"2009","journal-title":"Transplantation"},{"issue":"suppl","key":"10.1016\/j.healun.2010.01.005_bib14","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/j.healun.2005.01.011","article-title":"Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin","volume":"24","author":"Lehmkuhl","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.healun.2007.01.017","article-title":"Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up","volume":"3","author":"Rothenburger","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.healun.2008.07.020","article-title":"Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure","volume":"10","author":"Gonzalez-Vilchez","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1399-0012.2008.00795.x","article-title":"Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study","volume":"3","author":"Holdaas","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib18","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2005.01055.x","article-title":"A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0091270002042001011","article-title":"Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: a clinically relevant pharmacokinetic interaction","volume":"42","author":"Kovarik","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.healun.2010.01.005_bib20","unstructured":"Gullestad L, Iversen M, Mortensen A. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with reduced renal function: a multicenter, randomized trial. Transplantation (Epub ahead of print)."},{"key":"10.1016\/j.healun.2010.01.005_bib22","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/S0041-1345(01)02059-0","article-title":"ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications","volume":"3","author":"van Gelder","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2010.01.005_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2010.01.005_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.transproceed.2006.02.049","article-title":"Recommendations for use of everolimus after heart transplantation: results from a Latin-American Consensus Meeting","volume":"38","author":"Bocchi","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2010.01.005_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2010.01.005_bib26","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1600-6143.2005.00757.x","article-title":"First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation","volume":"4","author":"Meiser","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.healun.2007.08.014","article-title":"Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation","volume":"2","author":"Zuckermann","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2010.01.005_bib28","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0041-1345(03)00772-3","article-title":"Deterioration of renal function after replacement of cyclosporine with sirolimus in five patients with severe renal impairment late after heart transplantation","volume":"6","author":"Zakliczynski","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2010.01.005_bib29","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.TP.0000141094.34903.54","article-title":"Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients","volume":"78","author":"Vitko","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2010.01.005_bib30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.healun.2009.03.010","article-title":"Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease","volume":"6","author":"Stephany","year":"2009","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249810000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249810000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:21:16Z","timestamp":1760948476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249810000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1053249810000379"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2010.01.005","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2010.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}